Company Filing History:
Years Active: 2022
Title: Innovations of John Paul Madeley
Introduction
John Paul Madeley is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate p300 and CBP activity. His work has the potential to impact cancer treatment significantly.
Latest Patents
John Paul Madeley holds a patent for a process titled "Process for preparing modulators of p300 and/or CBP." This innovative process involves treating specific compounds to generate a promising modulator of p300/CBP activity. The compound produced has potential utility in treating various cancers, including prostate cancer, haematological cancers, bladder cancer, and lung cancer. He has 1 patent to his name.
Career Highlights
Madeley is currently associated with Cellcentric Limited, where he continues to work on groundbreaking research. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Throughout his career, John Paul Madeley has collaborated with esteemed colleagues such as Paul Baguley and Donald Alan Gilbert. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared goals in cancer research.
Conclusion
John Paul Madeley is a distinguished inventor whose work in modulating p300 and CBP activity holds promise for cancer treatment. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.